Immunocore Holdings (IMCR) Times Interest Earned (2021 - 2026)
Immunocore Holdings (IMCR) posted Times Interest Earned of $0.11 for Q1 2026, up 101.63% sequentially from -$6.45 in Q4 2025, and up 114.62% YoY from $0.05 in Q1 2025.
Powered by 
Analysis
Immunocore Holdings (IMCR) Times Interest Earned (2021 - 2026) Analysis & Trends
Immunocore Holdings has reported Times Interest Earned for 6 years, with the latest figure at $0.11 in Q1 2026.
- Quarterly Times Interest Earned rose 114.62% year-over-year to $0.11 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$0.5 (up 75.2% YoY) and the FY2025 annual result came in at -$0.23, up 70.35% from the prior year.
- Times Interest Earned grew to $0.11 in Q1 2026 per IMCR's latest filing, from -$6.45 in the prior quarter.
- Over five years, Times Interest Earned peaked at $3.46 in Q3 2022 and troughed at -$15.49 in Q2 2023.
- A 5-year average of -$5.23 and a median of -$3.05 in 2024 frame the typical range for Times Interest Earned.
- The sharpest annual moves came in 2022 and 2025: Times Interest Earned surged 114.71% in 2022, then tumbled 784.88% in 2025.
- Over 5 years, Times Interest Earned stood at -$7.03 in 2022, then plunged by 85.37% to -$13.03 in 2023, then soared by 85.26% to -$1.92 in 2024, then sank by 235.82% to -$6.45 in 2025, then jumped by 101.63% to $0.11 in 2026.
- According to Business Quant data, Times Interest Earned over the past three periods registered $0.11, -$6.45, and -$2.36 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | -493.00 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -21.24 |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 8.18 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 2.82 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 1.42 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -0.08 |
| 10 | Immunocore Holdings | 1.85 Bn | 965.54 Mn | 114.84 Mn | -0.98 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.98 |
| Mar 31, 2026 | 2.39 |
| Dec 31, 2025 | -6.45 |
| Sep 30, 2025 | -2.36 |
| Jun 30, 2025 | -4.89 |
| Mar 31, 2025 | -1.20 |
| Dec 31, 2024 | -2.76 |
| Sep 30, 2024 | -1.98 |
| Jun 30, 2024 | -3.74 |
| Mar 31, 2024 | -8.18 |
| Dec 31, 2023 | -13.03 |
| Sep 30, 2023 | -10.71 |
| Jun 30, 2023 | -10.08 |
| Mar 31, 2023 | -11.76 |
| Dec 31, 2022 | -7.03 |
| Sep 30, 2022 | 3.46 |
| Jun 30, 2022 | -11.78 |
| Dec 31, 2021 | -28.07 |
| Sep 30, 2021 | -23.50 |